Medical-device companies are doing well because elective-procedure volumes are finally back to their pre-pandemic levels—and are now even higher than those levels in many cases. To the extent that SWAV's procedures can be considered elective, SWAV ought to be a beneficiary of this trend.
Market Data 
Markets 
AI
